BeOne Medicines (BEIGF) Amortizatization of Intangibles (2018 - 2019)

BeOne Medicines (BEIGF) reported Amortizatization of Intangibles of -$51000.0 for Q3 2019, up 98.85% year-over-year from -$25647.3 in Q3 2018, and up 95.9% quarter-over-quarter from -$1.2 million in Q2 2019.

BeOne Medicines (BEIGF) Amortizatization of Intangibles (2018 - 2019) Analysis & Trends

BeOne Medicines (BEIGF) has 2 years of Amortizatization of Intangibles data on file, last reported at -$51000.0 in Q3 2019.

  • Amortizatization of Intangibles for Q3 2019 came in at -$51000.0, up 98.85% year-over-year; the trailing twelve-month figure through Sep 2019 was -$7.3 million (down 64.29% YoY), and the FY2018 annual result was -$8.0 million, changed N/A from the prior year.
  • Amortizatization of Intangibles climbed to -$51000.0 in Q3 2019 per BEIGF's latest filing, from -$1.2 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at -$51000.0 in Q3 2019 and troughed at -$4.4 million in Q3 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 821,726.73 Bn 821,726.69 Bn - -
2 Belite Bio 57,768.00 Bn 57,768.00 Bn - -
3 Quantum Biopharma 16,655.88 Bn 16,655.88 Bn - 13,267.00
4 Legend Biotech 3,540.00 Bn 3,539.71 Bn 242.10 Mn -
5 Evaxion A 1,526.26 Bn 1,526.24 Bn - -
6 Akari Therapeutics 1,520.09 Bn 1,520.09 Bn - -
7 Psyence Biomedical 223.87 Bn 223.87 Bn - -
8 Vertex Pharmaceuticals 114.47 Bn 107.23 Bn 2.59 Bn -
9 Abivax 91.22 Bn 91.22 Bn - -
10 BeOne Medicines - - 1.35 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2019 -51,000.00
Sep 30, 2019 -51,000.00
Jun 30, 2019 -1.24 Mn
Jun 30, 2019 -1.24 Mn
Mar 31, 2019 -2.41 Mn
Mar 31, 2019 -2.41 Mn
Dec 31, 2018 -3.59 Mn
Dec 31, 2018 -3.59 Mn
Sep 30, 2018 -4.44 Mn
Sep 30, 2018 -4.44 Mn